skip to Main Content

February 4, 2014

Codexis to Present at 16th Annual BIO CEO & Investor Conference

REDWOOD CITY, Calif., Feb. 4, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and complex chemistry industries, today announced that John Nicols, President and CEO of Codexis, will present a company overview at the 16th Annual BIO CEO & Investor Conference on Tuesday, February 11, 2014 at 1:00 p.m. ET in New York City.

A live webcast and replay will be available on the Investors section of the company’s website, http://ir.codexis.com/.

About Codexis, Inc.

Codexis, Inc. is a leading developer of biocatalysts for the pharmaceutical and complex chemistry industries. Codexis’ proven technology enables scale-up and implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable process development – from research to manufacturing. For more information, see www.codexis.com.

CONTACT: Codexis, Inc.
InvestorsPaul Cox, 212-362-1200
ir@codexis.com

MediaJemma Connor, +44 161 359 3255
jemma.connor@notchcommunications.co.uk


Codexis logo

Codexis

Back To Top
Close search
Search